Cargando…
Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults
SUMMARY: Mild, subacute COVID-19 in young people show inflammatory enhancement, but normal pulmonary function. Inflammatory markers are associated with age and male sex, whereas clinical symptoms are associated with age and female sex, but not with objective disease markers. BACKGROUND: Coronavirus...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864121/ https://www.ncbi.nlm.nih.gov/pubmed/35222429 http://dx.doi.org/10.3389/fimmu.2022.837288 |
_version_ | 1784655385190203392 |
---|---|
author | Lund Berven, Lise Selvakumar, Joel Havdal, Lise Stiansen-Sonerud, Tonje Einvik, Gunnar Leegaard, Truls Michael Tjade, Trygve Michelsen, Annika E. Mollnes, Tom Eirik Wyller, Vegard Bruun Bratholm |
author_facet | Lund Berven, Lise Selvakumar, Joel Havdal, Lise Stiansen-Sonerud, Tonje Einvik, Gunnar Leegaard, Truls Michael Tjade, Trygve Michelsen, Annika E. Mollnes, Tom Eirik Wyller, Vegard Bruun Bratholm |
author_sort | Lund Berven, Lise |
collection | PubMed |
description | SUMMARY: Mild, subacute COVID-19 in young people show inflammatory enhancement, but normal pulmonary function. Inflammatory markers are associated with age and male sex, whereas clinical symptoms are associated with age and female sex, but not with objective disease markers. BACKGROUND: Coronavirus Disease 2019 (COVID-19) is widespread among adolescents and young adults across the globe. The present study aimed to compare inflammatory markers, pulmonary function and clinical symptoms across non-hospitalized, 12 – 25 years old COVID-19 cases and non-COVID-19 controls, and to investigate associations between inflammatory markers, clinical symptoms, pulmonary function and background variables in the COVID-19 group. METHODS: The present paper presents baseline data from an ongoing longitudinal observational cohort study (Long-Term Effects of COVID-19 in Adolescents, LoTECA, ClinicalTrials ID: NCT04686734). A total of 31 plasma cytokines and complement activation products were assayed by multiplex and ELISA methodologies. Pulmonary function and clinical symptoms were investigated by spirometry and questionnaires, respectively. RESULTS: A total of 405 COVID-19 cases and 111 non-COVID-19 controls were included. The COVID-19 group had significantly higher plasma levels of IL-1β, IL-4, IL-7, IL-8, IL-12, TNF, IP-10, eotaxin, GM-CSF, bFGF, complement TCC and C3bc, and significantly lower levels of IL-13 and MIP-1α, as compared to controls. Spirometry did not detect any significant differences across the groups. IL-4, IL-7, TNF and eotaxin were negatively associated with female sex; eotaxin and IL-4 were positively associated with age. Clinical symptoms were positively associated with female sex and age, but not with objective disease markers. CONCLUSIONS: Among non-hospitalized adolescents and young adults with COVID-19 there was significant alterations of plasma inflammatory markers in the subacute stage of the infection. Still, pulmonary function was normal. Clinical symptoms were independent of inflammatory and pulmonary function markers, but positively associated with age and female sex. |
format | Online Article Text |
id | pubmed-8864121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88641212022-02-24 Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults Lund Berven, Lise Selvakumar, Joel Havdal, Lise Stiansen-Sonerud, Tonje Einvik, Gunnar Leegaard, Truls Michael Tjade, Trygve Michelsen, Annika E. Mollnes, Tom Eirik Wyller, Vegard Bruun Bratholm Front Immunol Immunology SUMMARY: Mild, subacute COVID-19 in young people show inflammatory enhancement, but normal pulmonary function. Inflammatory markers are associated with age and male sex, whereas clinical symptoms are associated with age and female sex, but not with objective disease markers. BACKGROUND: Coronavirus Disease 2019 (COVID-19) is widespread among adolescents and young adults across the globe. The present study aimed to compare inflammatory markers, pulmonary function and clinical symptoms across non-hospitalized, 12 – 25 years old COVID-19 cases and non-COVID-19 controls, and to investigate associations between inflammatory markers, clinical symptoms, pulmonary function and background variables in the COVID-19 group. METHODS: The present paper presents baseline data from an ongoing longitudinal observational cohort study (Long-Term Effects of COVID-19 in Adolescents, LoTECA, ClinicalTrials ID: NCT04686734). A total of 31 plasma cytokines and complement activation products were assayed by multiplex and ELISA methodologies. Pulmonary function and clinical symptoms were investigated by spirometry and questionnaires, respectively. RESULTS: A total of 405 COVID-19 cases and 111 non-COVID-19 controls were included. The COVID-19 group had significantly higher plasma levels of IL-1β, IL-4, IL-7, IL-8, IL-12, TNF, IP-10, eotaxin, GM-CSF, bFGF, complement TCC and C3bc, and significantly lower levels of IL-13 and MIP-1α, as compared to controls. Spirometry did not detect any significant differences across the groups. IL-4, IL-7, TNF and eotaxin were negatively associated with female sex; eotaxin and IL-4 were positively associated with age. Clinical symptoms were positively associated with female sex and age, but not with objective disease markers. CONCLUSIONS: Among non-hospitalized adolescents and young adults with COVID-19 there was significant alterations of plasma inflammatory markers in the subacute stage of the infection. Still, pulmonary function was normal. Clinical symptoms were independent of inflammatory and pulmonary function markers, but positively associated with age and female sex. Frontiers Media S.A. 2022-02-09 /pmc/articles/PMC8864121/ /pubmed/35222429 http://dx.doi.org/10.3389/fimmu.2022.837288 Text en Copyright © 2022 Lund Berven, Selvakumar, Havdal, Stiansen-Sonerud, Einvik, Leegaard, Tjade, Michelsen, Mollnes and Wyller https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Lund Berven, Lise Selvakumar, Joel Havdal, Lise Stiansen-Sonerud, Tonje Einvik, Gunnar Leegaard, Truls Michael Tjade, Trygve Michelsen, Annika E. Mollnes, Tom Eirik Wyller, Vegard Bruun Bratholm Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults |
title | Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults |
title_full | Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults |
title_fullStr | Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults |
title_full_unstemmed | Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults |
title_short | Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults |
title_sort | inflammatory markers, pulmonary function, and clinical symptoms in acute covid-19 among non-hospitalized adolescents and young adults |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864121/ https://www.ncbi.nlm.nih.gov/pubmed/35222429 http://dx.doi.org/10.3389/fimmu.2022.837288 |
work_keys_str_mv | AT lundbervenlise inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT selvakumarjoel inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT havdallise inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT stiansensonerudtonje inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT einvikgunnar inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT leegaardtrulsmichael inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT tjadetrygve inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT michelsenannikae inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT mollnestomeirik inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults AT wyllervegardbruunbratholm inflammatorymarkerspulmonaryfunctionandclinicalsymptomsinacutecovid19amongnonhospitalizedadolescentsandyoungadults |